Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Novartis AG Files SEBI Disclosure Confirming Non-Encumbrance of Shares and Sale Agreement Details
Novartis AG has confirmed to SEBI that there is no lien on its 1.74 crore equity shares, constituting a 70.68% stake in Novartis India Limited, as of March 31, 2026. This disclosure reaffirms the sale agreement from February 19, 2026, for the complete divestment of its promoter holding to three strategic acquirers: WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners. The filing ensures regulatory compliance and transparency regarding the divestment process.